FindTrial
Sign In

Prognostic value of progesterone receptor in solid pseudopapillary neoplasm of the pancreas: evaluation of a pooled case series

Prognostic value of progesterone receptor in solid pseudopapillary neoplasm of the pancreas: evaluation of a pooled case series

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018526
Enrollment
Unknown
Registered
2018-09-22
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid pseudopapillary neoplasm of the pancreas

Interventions

Positive or Negative progesterone receptor:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 70 Years

Inclusion criteria

Inclusion criteria: patients admitted in Pancreas Surgery Department of Wuhan Union hospital with confirmed diagnosis of solid pseudopapillary neoplasm of the pancreas in pathology from October 2018 to December 2020

Exclusion criteria

Exclusion criteria: patients confirmed diagnosis of not solid pseudopapillary neoplasm of the pancreas; patients without complete follow up information; patients with pancreatic malignant tumor or acute pancreatitis or other pancreatic diseases; patients with chemotherpy or adjuvant chemotherpy because of solid pseudopapillary neoplasm of the pancreas; patients with other clinical trail; patients are not suitable for this clinical trail

Design outcomes

Primary

MeasureTime frame
Disease free survival;—

Secondary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactHeshui Wu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

heshuiwu@hust.edu.cn+86 13720117761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026